top of page
Writer's pictureLarissa Mogano

BioLabs Partners with KLSAP Announces 2024 Accelerator Program Startups



October 3, 2024

BioLabs is excited to announce the three startups selected to participate in the Kansai Life Science Accelerator Program (KLSAP) 2024, a prestigious program aimed at helping life science startups expand globally. Launched in 2020, KLSAP provides startups with valuable mentoring sessions from U.S. life science experts, offering guidance on business growth and international expansion.


On September 13th, the KLSAP 2024 pitch event took place in Kobe, where many outstanding companies presented their innovative technologies. After careful evaluation, the following startups were chosen to join the KLSAP2024 Accelerator Program, which will begin in October 2024:

● Enterobiome Inc. – Jaegu Seo, CEO

● LinqMed Inc. – Yukie Yoshii, Ph.D., President & CEO

● Physiologas Technologies Inc. – Kazuyoshi Miyawaki, CEO


Additionally, LinqMed Inc. was honored with the Audience Award for their impressive pitch.

The 3-month KLSAP2024 Accelerator Program, supported by BioLabs, culminates in a Demo Day in January 2025, where the startups will present their innovations to potential alliance partners, investors, and development partners in the U.S.


BioLabs is proud to collaborate with KLSAP and support these talented startups on their journey to expand and thrive in the global life sciences ecosystem.


About BioLabs

BioLabs is a membership-based innovation platform and network of shared laboratory, BioLabs offers beautifully designed coworking environments that pair fully equipped and supported lab, office, and event spaces with relevant programming and unparalleled access to capital and industry partners. These fertile, supportive ecosystems allow young companies to shift their focus from startup operations to experimentation and innovation so they can reach their scientific potential quickly and achieve business success. Companies can start with a single lab bench and scale up as they grow. The expanding BioLabs network currently operates labs in the US: California; Connecticut; Massachusetts; New Jersey; North Carolina; New York City; Pennsylvania; Texas; Vermont; in Europe, Paris and Saclay, France, Heidelberg and Berlin, Germany, and in collaboration with iCONM in Tonomachi, Kawasaki, Japan. Learn more at https://www.biolabs.io


KLSAP 2024 PartnersThe Kansai Life Science Accelerator Program is organized by the Foundation for Biomedical Research and Innovation at Kobe and the City of Kobe, with support from key sponsors including Bayer Yakuhin Ltd., Celltrion, Inc., Sysmex Corporation, and AstraZeneca K.K., along with various organizations and government bodies, such as the Kyoto University Office of Institutional Advancement and Communications.


36 views0 comments

Commentaires


bottom of page